跳至主要内容
临床试验/CTRI/2022/11/047177
CTRI/2022/11/047177招募中未知

An Open-Label, Single-Arm, Prospective Clinical Study to Evaluate Efficacy and Safetyof Oral Glutathione capsule as a skin-lightening agent in Subjects with dark skin and Hyperpigmentation.

Gangwal Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Healthy Volunteers, men or women, from 18 to 60 years old.
  • 2.Having given their written, free and informed consent.
  • 3.Healthy subjects with skin type Fitzpatrick IV and V.
  • 4.Working indoor office jobs (for minimum 8 hours).

排除标准

  • 1.Personal or family history of skin cancer, especially melanoma.
  • 2.Consumption of any preparations containing glutathione within 1 month of enrolment.
  • 3.Use of any topical skin brightening or whitening preparations within 1 month of enrolment.
  • 4.Pigmentary disorders or any dermatoses, which may affect the measurement within the study areas.
  • 5.A pregnant or breastfeeding mother.
  • 6.Personal history of drug allergy or skin disorder due to side effects of oral therapy.
  • 7.Alcoholics and subjects with substance abuse.
  • 8.Subjects who have participated in other trial within last 3 months.
  • 9.Any other condition which the principal investigator thinks may jeopardize the study.

研究者

发起方
Gangwal Healthcare Pvt Ltd

相似试验